These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11952660)

  • 1. Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients.
    Kumar B; Saraswat A; Kaur I
    Clin Exp Dermatol; 2002 Jan; 27(1):8-13. PubMed ID: 11952660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blue lunula due to hydroxyurea.
    Jeevankumar B; Thappa DM
    J Dermatol; 2003 Aug; 30(8):628-30. PubMed ID: 12928534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis.
    Varma S; Lanigan SW
    Clin Exp Dermatol; 1999 May; 24(3):164-6. PubMed ID: 10354169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rediscovering hydroxyurea: its role in recalcitrant psoriasis.
    Kumar B; Saraswat A; Kaur I
    Int J Dermatol; 2001 Aug; 40(8):530-4. PubMed ID: 11703528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal melanonychia in a patient with essential thrombocytosis under treatment with hydroxyurea.
    Clerico R; Corsetti P; Ambrifi M; Paolino G; Rossi MR; Bottoni U; Calvieri S
    Acta Dermatovenerol Croat; 2012; 20(4):281-3. PubMed ID: 23317494
    [No Abstract]   [Full Text] [Related]  

  • 6. Nail pigmentation due to hydroxycarbamide.
    Ceulen RP; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption.
    Oh ST; Lee DW; Lee JY; Cho BK
    J Am Acad Dermatol; 2003 Aug; 49(2):339-41. PubMed ID: 12894095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea-induced hyperpigmentation with iron deposition.
    Lee KP; Vangipuram RK; Klimas NK; Sanyal S; Koshelev MV
    Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea-induced nail pigmentation in HIV patients.
    Joyner S; Lee D; Hay P; Lau R
    HIV Med; 1999 Oct; 1(1):40-2. PubMed ID: 11737328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of hydroxyurea in psoriasis.
    Smith CH
    Clin Exp Dermatol; 1999 Jan; 24(1):2-6. PubMed ID: 10233638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicoderma caused by hydroxyurea.
    Serrano-Falcón C; Pugnaire MAF; Del Mar Serrano-Falcón M; Morales MG; Serrano-Ortega S
    Int J Dermatol; 2011 Nov; 50(11):1435-1437. PubMed ID: 22004505
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary cutaneous effects of hydroxyurea: possible pathogenetic mechanisms.
    Zaccaria E; Cozzani E; Parodi A
    J Dermatolog Treat; 2006; 17(3):176-8. PubMed ID: 16854761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.
    Zargari O; Kimyai-Asadi A; Jafroodi M
    Pediatr Dermatol; 2004; 21(6):633-5. PubMed ID: 15575845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatomyositis-like eruption induced by hydroxyurea: a case report.
    Janerowicz D; Czarnecka-Operacz M; Stawny M; Silny W
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):131-4. PubMed ID: 19784527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin changes secondary to hydroxyurea therapy.
    Kennedy BJ; Smith LR; Goltz RW
    Arch Dermatol; 1975 Feb; 111(2):183-7. PubMed ID: 1054261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral squamous cell carcinoma during long-term treatment with hydroxyurea.
    De Benedittis M; Petruzzi M; Giardina C; Lo Muzio L; Favia G; Serpico R
    Clin Exp Dermatol; 2004 Nov; 29(6):605-7. PubMed ID: 15550132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lichenoid chronic graft-versus-host disease-like acrodermatitis induced by hydroxyurea.
    Eming SA; Peters T; Hartmann K; Scharffetter-Kochanek K; Mahrle G
    J Am Acad Dermatol; 2001 Aug; 45(2):321-3. PubMed ID: 11464207
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxyurea in the management of therapy resistant psoriasis.
    Layton AM; Sheehan-Dare RA; Goodfield MJ; Cotterill JA
    Br J Dermatol; 1989 Nov; 121(5):647-53. PubMed ID: 2597635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucocutaneous side effects of antineoplastic chemotherapy.
    Guillot B; Bessis D; Dereure O
    Expert Opin Drug Saf; 2004 Nov; 3(6):579-87. PubMed ID: 15500416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
    Saraceno R; Teoli M; Chimenti S
    Clin Ther; 2008 Jul; 30(7):1324-9. PubMed ID: 18691992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.